Cargando…

Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis

Hyaluronic acid (HA) is a glycosaminoglycan of extracellular matrix related to cell surface which interacts with various cell types. To understand the role of HA during hepatocarcinogenesis, we assessed the effect of the inhibition of HA deposition and its association with heterogeneous hepatocellul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sukowati, Caecilia H. C., Anfuso, Beatrice, Fiore, Esteban, Ie, Susan I., Raseni, Alan, Vascotto, Fulvia, Avellini, Claudio, Mazzolini, Guillermo, Tiribelli, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411988/ https://www.ncbi.nlm.nih.gov/pubmed/30858465 http://dx.doi.org/10.1038/s41598-019-40436-6

Ejemplares similares

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model
por: Anfuso, Beatrice, et al.
Publicado: (2018)

The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2015)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2013)

PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
por: Sukowati, Caecilia, et al.
Publicado: (2023)

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
por: Sukowati, Caecilia HC, et al.
Publicado: (2012)

4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
por: Rodríguez, Marcelo M., et al.
Publicado: (2021)

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
por: Cabral, Loraine Kay D., et al.
Publicado: (2020)

Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells
por: Sukowati, Caecilia H C, et al.
Publicado: (2021)

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2021)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2017)

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2018)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017)

The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways
por: Abruzzese, Vittorio, et al.
Publicado: (2022)

Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
por: Bianca, Claryssa, et al.
Publicado: (2022)

Treatment with the Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone Suppresses SEB-Induced Lung Inflammation
por: McKallip, Robert J., et al.
Publicado: (2013)

The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
por: Cabral, Loraine Kay D., et al.
Publicado: (2021)

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model
por: Anfuso, Beatrice, et al.
Publicado: (2020)

Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone as an Anti-Inflammatory Modulator of LPS-Mediated Astrocyte Responses
por: Chistyakov, Dmitry V., et al.
Publicado: (2020)

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
por: Anfuso, Beatrice, et al.
Publicado: (2019)

Antioxidant Activities of 4-Methylumbelliferone Derivatives
por: Al-Majedy, Yasameen K., et al.
Publicado: (2016)

Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis
por: Di Maso, Vittorio, et al.
Publicado: (2015)

Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models
por: Cabral, Loraine Kay D., et al.
Publicado: (2023)

Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation
por: Galkina, Svetlana I., et al.
Publicado: (2022)

Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2018)

The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations
por: Luong, An B., et al.
Publicado: (2020)

Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016)

Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts
por: Galgoczi, Erika, et al.
Publicado: (2020)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
por: Pascut, Devis, et al.
Publicado: (2019)

Novel 4-Methylumbelliferone Amide Derivatives: Synthesis, Characterization and Pesticidal Activities
por: Wei, Yan, et al.
Publicado: (2018)

(1)H-NMR dataset for hydroxycoumarins –Aesculetin, 4-Methylumbelliferone, and umbelliferone
por: dos Santos, Rui Galhano, et al.
Publicado: (2016)

4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication
por: Saga, Ryo, et al.
Publicado: (2021)

Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat
por: Gazzin, Silvia, et al.
Publicado: (2011)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
por: Tamura, Ryosuke, et al.
Publicado: (2014)

Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation
por: Steen, Emily H., et al.
Publicado: (2021)

4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing
por: Tsitrina, Alexandra A., et al.
Publicado: (2023)

Updates on Organoid Model for the Study of Liver Cancer
por: El-Khobar, Korri E., et al.
Publicado: (2023)

4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
por: Nagy, Nadine, et al.
Publicado: (2015)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Oral treatment of 4-methylumbelliferone reduced perineuronal nets and improved recognition memory in mice
por: Dubisova, Jana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s9ashh43dqe9rukn54lk0tuk4